1. Introduction {#s0005}
===============

The prevalence of diabetes mellitus in the latest clinical trials of congestive heart failure is as high as 30% and this number will increase, as the number of Type II diabetes mellitus patients is escalating.[@b0005]

Various mechanisms may link type 2 diabetes mellitus to heart failure: First; associated comorbidities such as hypertension may play a role; second; type 2 diabetes accelerates the development of coronary atherosclerosis; third; experimental and clinical studies support the existence of a specific diabetic cardiomyopathy.

In these patients the diabetic metabolic derangements, together with early activation of sympathetic nervous system, induce a decrease of myocardial function. The activation of renin-angiotensin system results in an unfavorable cardiac remodeling. The progression from myocardial damage to overt dysfunction and heart failure is often asymptomatic for a long time and frequently undiagnosed and untreated.

Epidemiological evidence in the community underscores the prevalence of the left ventricular systolic dysfunction in type 2 diabetic patients as 2- fold with respect to non-diabetic ones, with half of them completely asymptomatic. Diastolic dysfunction in type 2 diabetic hearts in comparison with non-diabetic is even more frequent.[@b0010]

The importance of assessing detailed information of LV myocardial performance in diabetic patients is essential in understanding the development of CHF and gives physicians the opportunity to initiate therapeutic intervention at an early stage.

Echocardiography has evolved as a well established tool for the non-invasive evaluation of regional and global myocardial function.

Two dimensional (2D) echocardiography is a simple, non-invasive technique that has been widely used to assess left ventricular function. However it has some limitations: First; 2-D echocardiography imaging using a gray scale does not always provide effective delineation of the endocardial border for a proper evaluation of regional wall motion in a significant subset of patients[@b0015]; Second, that technique depend to some extent on subjective judgment even when digital analysis is used, so search for superior techniques to quantify regional and global myocardial function has therefore continued.[@b0020]

Tissue Doppler imaging (TDI) echocardiography has the potential to analyze quantitatively the myocardial wall performance and can bring a new insights into the understanding of pathophysiology of heart disease. It is a non-invasive imaging modality that directly interrogates myocardial velocities throughout the cardiac cycle. As it does not depend on the amplitude of the reflected wave, it is possible to get information regarding myocardial wall motion from an area that may not have satisfactory gray- scale information on 2-D echocardiography.[@b0025]

During its initial application, tissue Doppler imaging (TDI) was limited to real-time visualization of only a single myocardial segment. Subsequent investigations in color-coded TDI and other technical improvements allowed a superior temporal and spatial resolution for simultaneous quantification of velocity data from multiple segments of the myocardium.[@b0030]

2. Objective {#s0010}
============

The aim of this study is to detect and quantify early subtle left ventricular (LV) systolic dysfunction using Tissue Doppler Imaging in type 2 diabetic patients with apparently normal LV ejection fraction.

3. Methods {#s0015}
==========

This study was approved by our institutional review board and informed consent was obtained from all individuals enrolled in the study.

3.1. Study population {#s0020}
---------------------

This was a prospective observational study which included patients referred to the echocardiography unit at the cardiology department, Ain Shams University Hospital. This study included 90 subjects divided into three groups:•**Group A**: Included thirty uncontrolled type II diabetic patients with HbAlc \> 8%.•**Group B**: Included thirty controlled type II diabetic patients with HbAlc \< 8%.•**Group C**: Control group included thirty non diabetic normal individuals with normal HbAlc \< 6%.

The exclusion criteria was as follows (i) inadequate Doppler signal, (ii) ischemic heart disease, (iii) cardiomyopathy, (iv) valvular heart disease, (v) other systemic disorders with cardiac involvement (systemic lupus, rheumatoid arthritis), (vi) systemic hypertension, (vii) pulmonary hypertension, (viii) left bundle branch block, (ix) patients with false positive HbAlc (chronic renal failure, chronic excessive alcohol intake), ***[(x) patients with arrhythmias(atrial fibrillation, premature ventricular or atrial extrasystoles)]{.ul}***.

3.2. Electrocardiography {#s0025}
------------------------

All subjects had a baseline 12-lead surface ECG performed. The ECG was examined for rate, rhythm, and whether or not Q wave, ST-T wave changes, or LBBB were present within one week of echocardiographic study.

3.3. Laboratory investigations {#s0030}
------------------------------

Including lipid profile, fasting and postprandial blood sugar, HbAlc.

3.4. Standard trans-thoracic echo- cardiographic study {#s0035}
------------------------------------------------------

All subjects were examined at rest and lying in the left lateral position. The measurement was made using general electric vivid 5 ultrasound system with tissue Doppler imaging option. A ***[3.5]{.ul}*** MHz phased array transducer was utilized.

All echocardiographic examinations were done by a senior echocardiographer with 10 years' experience in performing echocardiograms. To avoid personal bias in assessing the left ventricular functions, these parameters were graded by at least two experienced echocardiologists and in case of disparity, by a third one to ensure correct measurements.

2D echo was utilized to asses left ventricular systolic function by eye balling and by 2D Simpson on apical 4 and apical 2 chamber views ([Fig. 1](#f0005){ref-type="fig"}) as well as to rule out wall motion abnormality.Fig. 1Assessment of LV systolic function by 2D Simpson on apical 2 chamber view.

Pulsed Doppler was utilized to asses left ventricular diastolic function through mitral flow, measurements were obtained with the transducer in the A4C view, with the Doppler beam aligned perpendicular to the plane of the mitral annulus, the sample volume was placed between the tips of the mitral leaflets. Five consecutive beats during quiet respiration were used for calculation of the Doppler variables ([Fig. 2](#f0010){ref-type="fig"}).•Patients with regurgitant and stenotic valvular diseases were excluded.Fig. 2Assessment of LV diastolic function through mitral flow.

Color Doppler mode was used to evaluate left ventricular diastolic function by propagation flow velocity "Vp" by color M-mode that was performed in the apical four- chamber view and with the M-mode cursor aligned parallel with the LV inflow. Adjustments were made to obtain the longest column of flow from the mitral annulus to the apex of the left ventricle. The M-mode cursor was positioned through the centre of the inflow to avoid boundary regions. The velocity flow propagation was measured as the slope of the first aliasing velocity from the mitral annulus in early diastole to 4 cm distally into the ventricular cavity ([Fig. 3](#f0015){ref-type="fig"}).•Patients with regurgitant and stenotic valvular diseases were excluded.Fig. 3Evaluation of LV diastolic function by propagation flow velocity "Vp" by color M-mode.

3.5. Tissue Doppler imaging (TDI) {#s0040}
---------------------------------

Pulsed wave TDI study was accomplished at the end of expiration or with quiet respiration to minimize the effects of respiration. Assessment of left ventricular systolic function was done in the four-chamber view through detection of mitral annular velocities (Sm) at the junctions of mitral leaflets with LV lateral wall and inferoseptal regions ([Fig. 2](#f0010){ref-type="fig"}). When two systolic velocities, Sml and Sm2 were observed, the one with greater amplitude was recorded. Care was taken to align M-mode cursor so that the Doppler angle of incidence was as close to 0° as possible.

3.6. Statistical analysis {#s0045}
-------------------------

All data were gathered, tabulated, and statistically analyzed on a PC using a commercially available statistical software package MedCalc version 11.6.1.0 (MedCalc Software, Mariakerke, Belgium). Qualitative variables were expressed as frequency and percentage. Quantitative variables were expressed as mean + SD. Qualitative variables were compared using Chi-squared test. Quantitative variables were assessed using paired t-test. Correlations were performed with linear regression and Pearson's coefficient. Correlation coefficient and intra-class correlation were applied for the substudy to assess inter- and intra-observer variability. ROC Curve was generated to identify the cut off value of systolic dysfunction. P \< 0.05 was considered significant, and P \< 0.001 was considered highly significant.

4. Results {#s0050}
==========

The study included 90 patients divided into three groups:•**Group A**: Included thirty uncontrolled type II diabetic patients with HbAlc \> 8%.•**Group B**: Included thirty controlled type II diabetic patients with HbAlc \< 8%.•**Group C**: Control group included thirty non diabetic normal individuals with normal HbAlc \< 6%.

The age of the studied groups was ranging from 17 to 68 years. The mean age in years was 46.24 ± 11.99. It included 48 males (53.3 %) and 42 females (46.7 %).•In group A: the age was ranging from 33 to 68 years. The mean age in years was 48.2 ± 10.097. It included 16 males (53.3%) and 14 females (46.7%).•In group B: the age was ranging from 32 to 68 years. The mean age in years was 46.5 ± 11.227. It included 17 males (56.7%) and 13 females (43.3%).•In group C: the age was ranging from 17 to 67 years. The mean age in years was 44.03 ± 14.308. It included 15 males (50%) and 15 females (50%).--There was no statistically significant difference between the studied groups as regard age and sex.

4.1. Assessment of LV systolic and diastolic functions by conventional methods {#s0055}
------------------------------------------------------------------------------

Left ventricular diastolic function was assessed by Pulsed Doppler through mitral flow and also by Color Doppler by propagation flow velocity "Vp" in color M-mode. Left ventricular systolic function was assessed by 2D Simpson method and volumes. The results are shown in ([Table 1](#t0005){ref-type="table"}) and graphically represented in ([Fig. 4](#f0020){ref-type="fig"}).--There was significant statistical difference between the studied groups as regard peak E, E/A ratio and Vp. For peak A, There was no statistically significant difference when was compared between Diabetic controlled group vs. normal control group but there was significant statistical difference when compared between diabetic uncontrolled group vs. diabetic controlled and normal control groups. These data are shown in ([Table 2](#t0010){ref-type="table"}).Table 2Left ventricular diastolic and systolic function characteristics of the studied groups.Dependent variable(I) Groups(J) GroupsMean Difference (I-J)Sig.peak E^\*^Normal controlDM controlled12.57(\*)0.001^\*^DM uncontrolled25.03(\*)0.001^\*^DM controlledNormal control−12.57(\*)0.001^\*^DM uncontrolled12.47(\*)0.001^\*^DM uncontrolledNormal control−25.03(\*)0.001^\*^DM controlled−12.47(\*)0.001^\*^  peak A^\*^Normal controlDM controlled−1.97NSDM uncontrolled−13.9(\*)0.001^\*^DM controlledNormal control1.97NSDM uncontrolled−11.93(\*)0.001^\*^DM uncontrolledNormal control13.9(\*)0.001^\*^DM controlled11.93(\*)0.001^\*^  E/A ratioNormal controlDM controlled0.26(\*)0.001^\*^DM uncontrolled0.65(\*)0.001^\*^DM controlledNormal control−0.26(\*)0.001^\*^DM uncontrolled0.39(\*)0.001^\*^DM uncontrolledNormal control−0.65(\*)0.001^\*^DM controlled−0.39(\*)0.001^\*^  Vp^\*^Normal controlDM controlled16.98(\*)0.001^\*^DM uncontrolled30.08(\*)0.001^\*^DM controlledNormal control−16.98(\*)0.001^\*^DM uncontrolled13.103(\*)0.001^\*^DM uncontrolledNormal control−30.08(\*)0.001^\*^DM controlled−13.103(\*)0.001^\*^  EF(Mod Simpson 4C)Normal controlDM controlled0.4NSDM uncontrolled1.8NSDM controlledNormal control−0.4NSDM uncontrolled1.4NSDM uncontrolledNormal control−1.8NSDM controlled−1.4NS  EF (Mod Simpson 2C)Normal controlDM controlled0.3NSDM uncontrolled2.2NSDM controlledNormal control−0.3NSDM uncontrolled1.9NSDM uncontrolledNormal control−2.2NSDM controlled−1.9NS  LWs4cNormal controlDM controlled−1.92NSDM uncontrolled−2.36NSDM controlledNormal control1.92NSDM uncontrolled−0.44NSDM uncontrolledNormal control2.36NSDM controlled0.44NS  LWs2cNormal controlDM controlled−1.61NSDM uncontrolled−0.63NSDM controlledNormal control1.61NSDM uncontrolled0.98NSDM uncontrolledNormal control0.63NSDM controlled−0.98NS  EF(M-Mode)Normal controlDM controlled1.03NSDM uncontrolled2NSDM controlledNormal control−1.03NSDM uncontrolled0.97NSDM uncontrolledNormal control−2NSDM controlled−0.97NS  LVIDsNormal controlDM controlled0.063NSDM uncontrolled−0.019NSDM controlledNormal control−0063NSDM uncontrolled−0.082NSDM uncontrolledNormal control0.019NSDM controlled0.082NS--There was no statistically significant difference between the studied groups as regard conventional echocardiography measurements including ejection fraction by 2D Simpson on 4C view and 2C view, LVVs4c, LVVs2c, ejection fraction by M-mode and LVIDs. These data are shown in ([Table 2](#t0010){ref-type="table"}).Table 1LV systolic and diastolic function by conventional methods.Dependent variableGroupsNMinimumMaximumMeanStd. Deviationpeak E^\*^Normal control305712077.715.205DM controlled30448565.138.577DM uncontrolled30417252.678.735Total904112065.1715.159  peak A^\*^Normal control30378454.411.593DM controlled30428156.379.711DM uncontrolled304510368.312.135Total903710359.6912.675  E/A ratioNormal control301.141.981.440.225DM controlled300.81.781.170.233DM uncontrolled300.531.160.780.178Total900.531.981.130.343  Vp^\*^Normal control3053.7493.7274.3511.004DM controlled3038.0877.8157.3612.053DM uncontrolled3034.6264.2544.267.48Total9034.6293.7258.6616.007  EF(Mod Simpson 4C)Normal control30557466.15.148DM controlled30567465.74.843DM uncontrolled30547464.36.205Total90547465.375.425  EF(Mod Simpson 2C)Normal control30577566.234.384DM controlled30577665.934.996DM uncontrolled30547564.036.305Total90547665.45.321  LWs4cNormal control3022.5552.8336.0398.318DM controlled3023.5155.5237.9598.671DM uncontrolled3024.2957.8238.49.262Total9022.5557.8237.4668.721  LWs2cNormal control3019.1553.5936.338.275DM controlled3022.6155.3537.9449.055DM uncontrolled3023.3259.4636.9619.927Total9019.1559.4637.0789.032  EF(M-Mode)Normal control30577666.84.752DM controlled30587465.774.423DM uncontrolled30557664.85.798Total90557665.795.036  LVIDsNormal control302.364.033.2290.428DM controlled302.43.923.1660.454DM uncontrolled302.413.913.2490.478Total902.364.033.2150.450[^1][^2][^3][^4]Fig. 4Left ventricular systolic and diastolic function of studied groups by conventional echocardiography and by Tissue Doppler Imaging (a. LV diastolic function by Pulsed Doppler -- b. LV diastolic function by propagation flow velocity "Vp" -- c. LV systolic function by conventional method -- d. LV systolic function by TDI).

4.2. Assessment of LV systolic function by Tissue Doppler imaging {#s0060}
-----------------------------------------------------------------

Assessment of left ventricular systolic function for the studied groups was done by Tissue Doppler Imaging through detection of peak systolic velocities (Sm) of medial and lateral mitral annulus from A4C view. The results are shown in ([Table 3](#t0015){ref-type="table"}) and graphically represented in ([Fig. 4](#f0020){ref-type="fig"}).Table 3Comparison between the different studied groups regarding LV systolic function measured by TDI.NMin.Max.MeanStd. DeviationSm(Med. annulus)[a](#tblfn1){ref-type="table-fn"}Normal control306.911.28.221.09DM controlled306.510.27.91.04DM uncontrolled304.57.95.980.86Total904.511.27.371.42  Sm (Lat. annulus)[a](#tblfn1){ref-type="table-fn"}Normal control308.613.610.051.31DM controlled307.612.69.61.27DM uncontrolled305.38.46.740.87Total905.313.68.791.82[^5]

There was no statistically significant difference between diabetic controlled group and normal control group as regard Sm of medial and lateral annulus. But there was significant statistical difference when it was compared between the diabetic uncontrolled group vs. diabetic controlled and normal control groups. These data are shown in ([Table 4](#t0020){ref-type="table"}).Table 4Left ventricular systolic function characteristics of the studied groups by tissue Doppler imaging.Dependent variable(I) Groups(J) GroupsMean Difference (I-J)Sig.Sm (Med. annulus)Normal controlDM controlled0.32NSDM uncontrolled2.24(\*)0.001^\*^DM controlledNormal control−0.32NSDM uncontrolled1.92(\*)0.001^\*^DM uncontrolledNormal control−2.24(\*)0.001^\*^DM controlled−1.92(\*)0.001^\*^  Sm (Lat. annulus)Normal controlDM control0.45NSDM uncontrolled3.31(\*)0.001^\*^DM controlledNormal control−0.45NSDM uncontrolled2.86(\*)0.001^\*^DM uncontrolledNormal control−3.31(\*)0.001^\*^DM controlled−2.86(\*)0.001^\*^

4.3. ROC curve to determine the cut off value of LV systolic dysfunction by TDI {#s0065}
-------------------------------------------------------------------------------

Cut off value for systolic dysfunction detected by tissue Doppler imaging in uncontrolled diabetic patients was calculated. Results are represented as ROC curve (Receiver Operating Characteristic curve) in ([Fig. 5](#f0025){ref-type="fig"}) and analyzed in ([Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}).Fig. 5ROC curve of the cut off values for systolic dysfunction detected by TDI in uncontrolled diabetic patients.Table 5Area under the Curve.Test result variablesAreaSig.Sm (Med. annulus)0.7980.001[\*](#tblfn2){ref-type="table-fn"}Sm (Lat. annulus)0.8070.001[\*](#tblfn2){ref-type="table-fn"}[^6]Table 6Coordinates of the curve.Test result variablesPositive if lower than or equal toSensitivity\
%Specificity\
%Sm (Med. annulus)7 cm/s96%67%Sm (Lat. annulus)8.2 cm/s98%71%

In normal control and diabetic controlled groups, the mean peak systolic velocities of medial and lateral annulus were above the cut off values. However, in diabetic uncontrolled group the mean peak systolic velocities were below the cut off values. Percentages of patients with peak systolic velocity above and below the cut off values are shown in ([Table 7](#t0035){ref-type="table"}).Table 7Percentages of patients with Sm above and below the cut off values.GroupsMedial annulusLateral annulusTotalSm \> 7Sm \< 7Sm \> 8.2Sm \< 8.2Normal control No.29130030%96.6%3.4%100%0%100%DM controlled No.23725530%76.6%23.4%83.3%16.7%100%DM uncontrolled No.32712930%10%90%3.4%96.6%100%

5. Discussion {#s0070}
=============

Diabetes increases the risk of heart failure independent of coronary heart disease and hypertension and may cause a cardiomyopathy. Diabetic cardiomyopathy has been defined as ventricular dysfunction that occurs in diabetic patients independent of a recognized cause (eg, coronary heart disease, hypertension).[@b0035]

This is thought to result from microangiopathy, deposition of collagen, decreased expression/activation of the K+ channel and Na+ pump and decreased myofilament Ca2+ sensitivity.[@b0040]

Evidence of diastolic dysfunction appears early in the natural history of type 2 diabetes mellitus and evidence of impaired systolic function may subsequently become apparent. Even a mild degree of myocardial dysfunction has prognostic impact. Accordingly, there is a need for a sensitive and easily applied technique for the detection and follow-up of myocardial dysfunction in the diabetic patient before clinical evidence of compromised cardiac function is apparent.[@b0045]

In recent Doppler echocardiographic studies with analysis of combined mitral and pulmonary venous flow and flow during the Valsalva maneuver, abnormal LV diastolic filling was demonstrated to be present in approx. 50% of normotensive patients with Type II diabetes mellitus with normal systolic function[@b0050] However, LV systolic function is often described in terms of LVEF or fractional shortening (FS), reflecting global and radial shortening of the left ventricle, whereas the longitudinal systolic contraction of the outer and inner layer of the myocardium contributes less in these parameters.[@b0005]

In 1972, Rubier et al. described a specific type of cardiomyopathy related to diabetes mellitus.[@b0055]

Many epidemiologic studies indicate that patients with DM are at an increased risk of cardiovascular morbidity and mortality.[@b0060] A leading cause of death in patients with DM is heart failure, and patients with DM have a worse prognosis after myocardial infarction.[@b0065]

Clinical studies using conventional echocardiography have shown only global diastolic dysfunction, with a prevalence of about 60% in patients with Type II diabetes who have no clinically detectable heart disease.[@b0070]

Recent studies have examined left ventricular (LV) function in patients with type 2 DM. Abnormalities in diastolic function have been well confirmed, but abnormalities in systolic function are controversial and inconsistent.[@b0075] Part of the inconsistency may be related to concomitant myocardial ischemia and/or scar due to either macrovascular or microvascular coronary artery disease (CAD).[@b0080]

Radial function of the left ventricle is due mainly to contraction of circumferential myocardial fibres in the mid-wall, whereas long-axis function is governed by longitudinal subendocardial fibres.[@b0085]

Since the subendocardium is more vulnerable to ischemia and interstitial fibrosis, measurement of the velocity of longitudinal shortening of the ventricle by Tissue Doppler imaging may be a more sensitive marker of subclinical changes in LV performance in diabetes than assessment of global function by conventional echocardiographical methods.[@b0040]

The present study was undertaken for the purpose of early detection and quantification of left ventricular systolic dysfunction in type 2 diabetic patients using Tissue Doppler Imaging.

This study included 90 subjects divided into three groups, 30 uncontrolled type 2 diabetic patients, 30 controlled type 2 diabetic patients and 30 normal subjects served as controls.

In the present study, the studied groups were not statistically different in age and gender by selection of sex and age matched subjects in the three studied groups.

In view of assessment of left ventricular diastolic function, studying the mean peak early mitral inflow velocity E wave, the Strong Heart Study documented lowest E wave in diabetic patients compared to non-diabetic patients (p \< 0.05).[@b0090]

Hameedullah et al., compared patients with poorly controlled vs. moderately controlled and well controlled diabetic condition. The E wave was higher in well controlled patients than in poor controlled diabetic patients.[@b0095]

In the present study the mean peak early mitral inflow velocity E wave was lowest in patients whose diabetic condition was uncontrolled in comparison to patients whose diabetic condition was controlled and the normal control group, with a highly significant statistical difference.

The mean peak late mitral inflow velocity A wave, in the Strong Heart Study results, was higher in diabetic patients than in non diabetic patients.[@b0090]

Mehrdad et al., proved that the mean peak pulse Doppler A wave velocity was higher in diabetic group (when compared with non diabetic group, *p \< 0.05)* with positive correlation with HbAlc level.[@b0100]

In the present study the mean peak late mitral inflow velocity A wave (cm/Sec) was highest in uncontrolled diabetic patients than in controlled diabetic patients and normal control group with a high significant statistical difference.

The Strong Heart Study showed a stepwise decrease in the E/A ratio from the normotensive nondiabetic group to those with either condition to the combined hypertensive diabetic group. The E/A ratio was lowest in patients having worse glycaemic control (as indicated by higher levels of hemoglobin A1C and fasting glucose).[@b0090]

Mehrdad et al., showed a negative correlation of HbAlc with E/A ratio.[@b0100]

In the current study the E/A ratio showed stepwise decrease from normal individuals to patients with well controlled diabetic status to poorly controlled diabetic status with highly significant statistical difference.

In Andersen et al., the color M-mode flow propagation velocity of early diastolic flow (cm/s) was significantly decreased in diabetic patients compared with the controls subjects.[@b0005] However, in Wojciech et al., the decreased flow propagation velocity in diabetic patients compared to the controls subjects didn't reach a statistically significant difference.[@b0105]

In the present study the flow propagation velocity in uncontrolled diabetic patients show significant decrease when compared to controlled diabetic patients and normal control individuals.

During assessment of global systolic function by conventional echocardiography, Andersen et al., didnot find any statistical significant difference between diabetic patients and normal individuals while comparing LV end systolic dimension, Fractional shortening, LV volumes and ejection fraction by Simpson's modified biplane method.[@b0005]

This result was confirmed by Zhi et al., when the LV end systolic dimension, Fractional shortening, LV volumes and ejection fraction by the triplane three- dimensional method in three standard apical views (apical four, two and apical long) were compared between diabetic patients vs. normal individuals, and again showed no statistically significant difference.[@b0110]

Also many others studies confirmed no statistically significant difference between diabetic patients and normal individuals in ejection fraction by Simpson's modified biplane method.[@b0005], [@b0105], [@b0040]

Hameedullah et al., proved that when compared patients with poor controlled vs. moderate controlled and well controlled diabetic condition, the LV end diastolic dimension, LV end systolic dimension, ejection fraction by 2D guided M-Mode and Fractional shortening showed no statistically significant difference.[@b0095]

In the present study, there was no statistically significant difference between uncontrolled diabetic patients, controlled diabetic patients and normal control individuals as regards the LV volumes, ejection fraction by Simpson's modified biplane method, LV end-systolic internal dimension and ejection fraction by 2D guided M-mode. And this was concordant with results of previous studies. We can thus observe a consensus of all studies about absence of any overt systolic dysfunction assessed by conventional echo techniques related to diabetic status including the present study.

In view of assessment of systolic function by Tissue Doppler Imaging, Helene et al., found that the mean peak longitudinal systolic velocity was not significantly different between diabetic patients and control individuals using TDI at rest. While with dobutamine stress TDI, diabetic patients showed significant decrease in systolic velocity (p \< 0.05) demonstrating an impaired myocardial response in diabetic patients during stress.[@b0045]

In Andersson et al., comparing diabetic patients without significant CAD vs. control individuals, the mean peak longitudinal systolic velocity was significantly decreased in diabetic patients (p = 0.02) and the presence of hypertension was not found to modify the impairments of the systolic velocity.[@b0115]

In our study, comparing controlled diabetic patients vs. normal individuals, the mean peak longitudinal systolic velocity was not significantly different between the two groups, and this was concordant with results in Helene et al. as diabetic patients in Helene et al. study were mainly controlled diabetic patients with mean HbAlc 6.8 ± 1.4% matching controlled diabetic patients in our study with HbAlc \< 8%. There were no uncontrolled diabetic patients in Helene et al. study. While comparing uncontrolled diabetic patients to controlled diabetic patients and normal individuals, revealed a mean peak longitudinal systolic velocity that's significantly decreased in uncontrolled diabetic patients (p = 0.001).

For clinical application, we calculated the cut off value for systolic dysfunction detected by TDI in uncontrolled diabetic patients in the present study. Peak systolic velocities \< 7 cm/s for medial mitral annulus and \<8.2 cm/s for lateral mitral annulus were indicators of systolic dysfunction in diabetic patients, with sensitivity and specificity of 96% and 67% for medial mitral annulus and 98% and 71% for lateral one.

Applying these cut off values on our subjects' data, 90% of uncontrolled diabetic patients (27 patients) had peak systolic velocity of medial mitral annulus \< 7 cm/s with mean peak systolic velocity 5.98 cm/s, and 96.6% of these patients (29 patients) had peak systolic velocity of lateral mitral annulus \< 8.2 cm/s with mean peak systolic velocity 6.74 cm/s. On the other hand, 76.6% of controlled diabetic patients (23 patients) and 96.6% of normal individuals (29 subjects) had peak systolic velocity of medial mitral annulus \> 7 cm/s with mean peak systolic velocity 7.9 and 8.22 cm/s respectively. While for lateral mitral annulus, 83.3% of controlled diabetic patients (25 patients) and 100% of normal individuals (30 subjects) had peak systolic velocity \> 8.2 cm/s with mean systolic velocity 9.6 and 10.05 cm/s respectively.

In Gulati et al., color-coded TDI was compared to radionuclide ventriculography, which served as a standard of reference of left ventricular ejection fraction. TDI color M-modes echocardiograms were obtained from six mitral annular sites, including inferoseptal and lateral images from apical 4-chamber views, anterior and inferior images from apical 2-chamber views, and anteroseptal and posterior images from apical long axis views ([Fig. 5](#f0025){ref-type="fig"}). The peak mitral annular descent velocity average \> 5.4 cm/s had a sensitivity and specificity of 88 and 97 percent for an ejection fraction greater than 50 percent.[@b0120]

Collecting results of our study with these of Gulati et al. study, we may consider patients with peak mitral annular systolic velocity \> 5.4 cm/s, but \<7 cm/s for medial mitral annulus and \<8.2 cm/s for lateral mitral annulus, patients having systolic dysfunction with preserved ejection fraction. Conventional echocardiography may fail to detect these cases.

5.1. Study limitations and recommendations {#s0075}
------------------------------------------

The extensive exclusion criteria applied to the patients before enrolment in the study may suggest that the population is not a real-world population. The main objective of this extensive exclusion criteria was to try to document the presence of subtle changes in LV systolic functions related to DM and not to any other disease process and to test the effect of level of control of diabetes on these changes.

Correlation of decreased LV systolic function by TDI in uncontrolled diabetic patients and future development of LV systolic dysfunction using long term studies should be considered. Such a correlation if proved together with the results of the current study will further support our recommendation to consider tight blood sugar control for patients with subtle LV systolic dysfunction in order to protect these patients from developing progressive LV systolic dysfunction.

6. Conclusion {#s0080}
=============

TDI is a simple and effective method for detection of subtle LV systolic dysfunction in type 2 uncontrolled diabetic patients.
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[^1]: Results of peak E, peak A and Vp are shown in cm/s.

[^2]: LWs4c: left ventricular end systolic volume in 4 C view (cm^3^).

[^3]: LWs2c: left ventricular end systolic volume in 2 C view (cm^3^).

[^4]: LVIDs: left ventricular end systolic internal dimension (cm).

[^5]: Results of Sm are shown in cm/s.

[^6]: Highly significant.
